Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Type 2 Diabetes”

4,958 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,958 results

Post-approval studies (Phase 4)Study completedNCT02439879
What this trial is testing

Alpha Lipoic Acid for Treatment of Diabetic Neuropathy

Who this might be right for
Diabetic Neuropathy
Universidad Popular Autónoma del Estado de Puebla 45
Not applicableStudy completedNCT00005479
What this trial is testing

Diabetes, Lipoproteins and Accelerated Vascular Disease

Who this might be right for
Cardiovascular DiseasesHeart DiseasesCoronary Disease+4 more
Columbia University 164
Not applicableStudy completedNCT04042441
What this trial is testing

A Research Study, Looking at How Ryzodeg® (Insulin Degludec/Insulin Aspart) Works in People With Type 2 Diabetes in Local Clinical Practice

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 1,122
Not applicableNot Yet RecruitingNCT02569151
What this trial is testing

20 Years Results by HBP and DBP in Patients With Type 2 Diabetes Mellitus After Following-up

Who this might be right for
Diabetes Mellitus
Kyuzi Kamoi 600
Post-approval studies (Phase 4)Not Yet RecruitingNCT06501651
What this trial is testing

Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy

Who this might be right for
Essential HypertensionType 2 DiabetesNephropathy
Sichuan Academy of Medical Sciences 297
Large-scale testing (Phase 3)Ended earlyNCT00970424
What this trial is testing

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone

Who this might be right for
Diabetes Mellitus, Type II
Forest Laboratories 252
Not applicableStudy completedNCT02666924
What this trial is testing

Cooking Classes for Chinese Canadian Patients Living With Diabetes

Who this might be right for
Diabetes Mellitus Type 2
Vancouver General Hospital 81
Post-approval studies (Phase 4)Not Yet RecruitingNCT06762223
What this trial is testing

Henagliflozin on Liver Fibrosis in Patients with MASLD and T2DM

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver DiseaseType 2 Diabetes Mellitus
Xiqiao Zhou 190
Not applicableStudy completedNCT04484883
What this trial is testing

Performance of Six Equations for Estimating Resting Energy Expenditure in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 250
Not applicableStudy completedNCT04216654
What this trial is testing

Role of Helicobacter Pylori in Microalbuminuria

Who this might be right for
Microalbuminuria Due to Type 2 Diabetes Mellitus
Minia University 200
Testing effectiveness (Phase 2)UnknownNCT04304560
What this trial is testing

Value of SGLT2 Inhibitor (Dapagliflozin) as an Added Therapy in Diabetic Patients With Heart Failure With Reduced Ejection Fraction; Randomized Controlled Clinical Trial

Who this might be right for
Heart Failure With Reduced Ejection Fraction (HFrEF)Diabete Type 2Cardiomyopathies
Damanhour University 60
Post-approval studies (Phase 4)Study completedNCT00318656
What this trial is testing

24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes

Who this might be right for
Non-Insulin-Dependent Diabetes Mellitus
GlaxoSmithKline 23
Early research (Phase 1)Study completedNCT04930679
What this trial is testing

Evaluating Safety of Andiabet on Diabetes Mellitus Type II Patients, Phase I CT.

Who this might be right for
Diabetes Mellitus, Type 2
Centre of Clinical Pharmacology, Hanoi Medical University 14
Post-approval studies (Phase 4)Not Yet RecruitingNCT07311551
What this trial is testing

A Comparison of Effectiveness, Safety, and Cost-effectiveness of Dapagliflozin and Empagliflozin in Patients With Type 2 Diabetes Mellitus and High Body Mass Index (BMI)

Who this might be right for
Type 2 Diabetes
Bhavya Bhavya, MD 112
Not applicableStudy completedNCT01351922
What this trial is testing

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in India

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 12,000
Post-approval studies (Phase 4)UnknownNCT04706637
What this trial is testing

A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and Dapagliflozin

Who this might be right for
Bone Diseases, MetabolicDiabetes Mellitus, Type 2
Kyung Hee University Hospital at Gangdong 120
Large-scale testing (Phase 3)Study completedNCT04429503
What this trial is testing

Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease

Who this might be right for
Diabetic Macular EdemaType 1 Diabetes MellitusType 2 Diabetes Mellitus
Regeneron Pharmaceuticals 660
Not applicableLooking for participantsNCT06593327
What this trial is testing

NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study

Who this might be right for
Type 2 DiabetesDiabetic CardiomyopathyHeart Failure+1 more
University of Texas Southwestern Medical Center 300
Not applicableUnknownNCT05919927
What this trial is testing

Diabetes and Cognitive Functions in Middle Age

Who this might be right for
Diabetes Mellitus, Type 2Cognitive ImpairmentHyperglycemia+2 more
Tampere University Hospital 120
Not applicableLooking for participantsNCT06273761
What this trial is testing

Evaluation of Medication Management Service

Who this might be right for
Medication AdherenceMedication SafetyDiabetes Mellitus, Type 2+3 more
The University of Hong Kong 640
Load More Results